Stay Updated with the Latest Mach7 Technologies Limited M7T.AX News in Real Time
Find M7T.AX news now at Meyka AI. Stay informed with the latest Mach7 Technologies Limited stocks updates, including price news, market analysis, and expert insights.
HUDCO (NSE: HUDCO) Shares Jump Over 3% as Q1 Loan Sanctions Surge 93% YoY to ₹65,485 Crore
Housing and Urban Development Corporation (HUDCO) began FY2026-27 on a strong note with provisional Q1 business numbers released on July 1, 2026. The state-owned lender reported a 93% year-on-year jump in loan sanctions to ₹65,485 crore, while loan disbursements also posted solid growth. The update pushed HUDCO shares up more than 3% in early trade,…
Tata Elxsi (NSE: TATAELXSI) and Tata Technologies Shares Fall Up to 6% as KPIT’s Weak Q1FY27 Outlook Weighs on Sentiment
On July 1, 2026, shares of Tata Elxsi and Tata Technologies dropped by up to 6% after KPIT Technologies issued a weaker-than-expected business outlook for Q1FY27. The update raised fresh concerns about slowing demand in the global automotive technology sector, especially from European carmakers. Although the Tata companies made no negative announcements of their own,…
KPIT Technologies Share Price Slides 15% to ₹570 After Weak Q1 FY27 Business Update
KPIT Technologies shares crashed to a fresh 52-week low on July 1, 2026. The stock hit ₹570.75 on the BSE, a 15% intraday decline from the previous session close of ₹671.45 after the Pune-based automotive software company issued a profit warning late on June 30, 2026. KPIT flagged a sudden revenue shortfall in Q1 FY27…
Microsoft Layoffs: MSFT Cuts Up to 2.5% of Jobs, Targets Xbox and Sales Divisions
Microsoft is preparing another round of layoffs as it begins its 2027 fiscal year, with reports on June 30, 2026, indicating that up to 2.5% of its global workforce could be affected. The planned cuts are expected to focus on Xbox, sales, and consulting teams while the company continues investing heavily in artificial intelligence. The…
Zee Media Share Price Rises 1% After ₹19.12 Crore Fundraise; FII Upps Stake to 3.33% via Warrant Conversion
Zee Media’s shares rose nearly 1% after the company announced a fresh capital infusion of ₹19.12 crore through warrant conversion. The move also pushed Foreign Institutional Investor (FII) ownership to 3.33%, highlighting growing institutional interest in the media company. The development comes as investors look for signs of recovery and stronger financial positioning in India’s…
IN Market Today: Sensex Gains 173 Points (+0.23%), Nifty 50 Rises 0.27%; GIFT Nifty Trades Lower
India’s benchmark indices closed the June quarter on a subdued note. The BSE Sensex fell 249.70 points, or 0.33%, to close at 76,478.67, while the Nifty 50 declined 80.50 points, or 0.34%, to settle at 23,865.75, slipping below the 23,900 mark. IT stocks led the selloff. GIFT Nifty futures declined 71 points, or 0.3%, to…
Tech Stocks Recover Across Asia After Nasdaq’s 2% Surge, but Regional Markets Remain Cautious
The Nasdaq Composite surged more than 2% on June 29, 2026, giving global tech stocks a much-needed boost after weeks of market volatility. The rally quickly spread to Asia, where chipmakers and AI-related companies led early gains in Japan, South Korea, and Taiwan. Yet investors are still moving carefully. Concerns about high valuations, geopolitical tensions,…
Apple Inc News: 5 Billion Devices Affected by AirDrop and Quick Share Security Flaw
Apple Inc (NASDAQ: AAPL) faces fresh scrutiny after researchers disclosed major proximity-sharing vulnerabilities on June 30, 2026. Six AirDrop and Quick Share vulnerabilities span iOS, macOS, Android, and Windows, affecting protocols on over five billion active devices. Researchers at the CISPA Helmholtz Center for Information Security examined both systems and uncovered the flaws. Apple, Google,…
Abivax Shares Soar 27% After Ulcerative Colitis Drug Shows Strong Results in Hard-to-Treat Patients
Abivax shares surged sharply after new clinical trial results for its ulcerative colitis treatment, obefazimod, showed strong performance in patients who previously failed standard therapies. The stock reaction reflects renewed investor confidence in the biotech pipeline and growing hopes for a breakthrough therapy in a difficult disease area. The move also comes at a time…